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Abstract
Earlier studies indicate that genotyping of Mycobaterium leprae based on single-nucleotide polymorphisms (SNPs) is useful for analysis of the
global spread of leprosy. In the present study, we investigated the diversity of M. leprae at eight SNP loci using 180 clinical isolates obtained
from patients with leprosy residing mainly in Delhi and Purulia (West Bengal) regions. It was observed that the frequency of SNP type 1 and
subtype D was most predominant in the Indian population. Further, the SNP type 2 subtype E was noted only from East Delhi region and
SNP type 2 subtype G was noted only from the nearby areas of Hoogly district of West Bengal. These results indicate the occurrence of
focal transmission of M. leprae infection and demonstrate that analysis by SNP typing has great potential to help researchers in
understanding the transmission of M. leprae infection in the community.
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Leprosy, caused by Mycobacterium leprae, is a chronic infectious
disease affecting primarily the peripheral nerves, skin and
mucous membranes. It is one of the oldest recorded diseases
of humankind. Even today, leprosy remains a major health
problem in 130 countries of the world, excluding the small
number of cases in Europe [1]. In spite of considerable
research efforts made during the past few years, the nature of
transmission and the possibility of existence in environmental
reservoirs other than humans of M. leprae [2,3] have eluded
the researchers investigating the occurrence of continuous
transmission of disease in endemic regions. In 130 countries
worldwide, at the beginning of 2010 the total number of new
cases were 192 246 and during the year 2011 a total of
228 474 new cases of leprosy were detected [1]. In India, a
total of 127 000 new cases were detected during the year
2011–12 with an annual new case detection rate of 10.35 per
100 000 population and a prevalence of 0.68 per 10 000 of the
population. Till now 32 States/Union Territories have attained
leprosy elimination. Even now, after two decades of multi-drug
therapy there are 11 districts with annual new case detection
rates > 50/100 000 population: in Chhattisgarh, Gujarat,
Maharashtra, West Bengal, Dadra & Nagar Haveli, Orissa
and Delhi [4]. At this juncture of elimination, there is a need to
develop suitable techniques and tools for understanding the
epidemiology of leprosy and identify sources as well as reasons
for the persisting load of infection. Even after years of global
campaigns on elimination of leprosy and rigorous case ﬁnding
along with the availability of multi-drug therapy regimens [5–7],
its continued occurrence strongly implies the existence of
subclinical human and environmental reservoirs of the path-
ogen [8,9].
In recent years, molecular strain-typing methodologies have
added to our understanding and deciphering of complicated
conventional infectious disease epidemiology. With the
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discovery of the complete genome sequence for M. leprae
isolated from Tamil Nadu, India—called the TN strain [10]—
selection of potential polymorphic genomic markers for strain
typing has become feasible. The ﬁrst genetic markers that
showed polymorphism were short tandem repeats in the
M. leprae genome. One was a 6-bp intragenic sequence in the
rpoT gene, and the second, a trinucleotide (TTC) repeat
element—upstream of a pseudogene [11,12]. These sequences
exhibit variable numbers of tandem repeats when sequenced
from different isolates. Many genetic ﬁngerprinting methods
have been applied for M. leprae characterization, including
insertion elements like pol(A) [13], restriction fragment length
polymorphism analysis of the heatshock protein 65 gene [14],
variable numbers of tandem repeats analysis [15–17] and
single-nucleotide polymorphisms (SNPs) [18–21]. Among
these, SNP and variable numbers of tandem repeats typing
were the only methods to reveal any genetic diversity among
M. leprae strains. In the present study we carried out SNP
subtyping of the clinical isolates from different regions of India.
Material and Methods
In the present study, M. leprae strains were obtained from
patients with a clinical diagnosis of leprosy. Ethical approval to
use the diagnostic specimens for researchwas obtained from the
ethics review board of The Leprosy Mission Trust (TLM), India.
Collection of specimens
A total of 180 slit skin scrapings obtained from leprosy patients
who attended the Outatient Departments of the TLM
Community Hospitals of Shahdara (Delhi), Naini (UP), Purulia
(West Bengal) and Miraj (Maharashtra) during 2007–10, were
included in the study. Slit skin scrapings were obtained from
these patients for the SNP typing analysis (Table 1). All 180
multibacillary cases were diagnosed and classiﬁed by standard
clinical criteria (NLEP guidelines: http://nlep.nic.in/).
Extraction of genomic DNA
NHDP63 and Thai 53 DNA, obtained from Colorado State
University (Fort Collins, CO, USA) were used as reference
strains. Genomic DNA was isolated by cell wall disruption with
proteinase K and 0.1 M Tris–HCl as described previously [22].
The reaction was terminated at 97°C for 15 min. This lysate
preparation was then used for PCR.
SNP typing and subtyping
The M. leprae SNP loci 1, 2 and 3 (nucleotide positions 14676,
1642875 and 2935685, respectively, on the sequenced TN
strain) were ampliﬁed using previously reported primer
sequences and protocol [18,23].
Subtyping of SNP type 1 (nucleotide positions 8453, 313361,
61425 and 1642879, respectively) and type 2 (nucleotide
positions 310278, 1104235, 2751790 and 2935693) was
carried out using previously reported primer sequences and
ampliﬁcation conditions [19].
Sequencing of PCR products was outsourced to a com-
mercial company (Xplorigen Technologies Pvt Limited; Delhi,
India). Sequence data were analysed further by using CODON-
CODE ALIGNER 4.0.3.
Results
Distribution of SNP M. leprae genotypes
The SNP types detected were limited to SNP type 1, CGA and
SNP type 2, TAC. In this study, the SNP type 1 was identiﬁed
in 166 samples, whereas the SNP type 2 was detected in only
15 samples (Table 2, Supplementary ﬁles).
The SNP subtyping of samples from leprosy endemic areas
in Delhi and UP showed similar patterns (2E) in eight strains.
SNP subtype 2G was observed from Purulia, West Bengal
(Fig. 1).
Clustering of SNP subtype 2E from a local area of East Delhi
We analysed 65 samples from Delhi and UP and found that
the D subtype was predominant in this area. We observed
that subtype 2E was clustered in a local area of north-east
Delhi where old leprosy patients were residing (Table 3a,
Fig. 2).
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TLM, The Leprosy Mission Trust.
TABLE 2. Distribution of genotypes in different areas of
India
Area SNP type 1 SNP type 2
Subtype loci (A) (B) (C) (D) (E) (F) (G) (H)
Purulia (100) 2 0 18 75 0 0 5 0
Delhi (41) 1 0 2 31 7 0 0 0
UP (24) 0 0 7 15 1 0 1 0
Miraj (15) 0 0 2 13 0 0 0 0
Total (180) 3 0 29 134 8 0 6 0
SNP, single-nucleotide polymorphism.
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Clustering of SNP subtype 2G from a local area of Hoogly,
West Bengal
We analysed 100 samples from West Bengal and found that
the D subtype was predominant in this area. Subtype 2G was
clustered in a coastal part of West Bengal (Hoogly) where old
leprosy patients were residing (Table 3b, Fig. 1).
Discussion
Leprosy is almost exclusively a disease of the developing
world, affecting mainly areas of Asia, Africa, Latin America and
the Paciﬁc. Africa and Asia have the maximum disease burden.
Within endemic locales the distribution of leprosy is not
uniform, and areas of high prevalence sometimes border areas
of very low prevalence with little or no disease. The global
registered prevalence of leprosy was 192 246 at the beginning
of 2011 [1]. Despite the administration of multi-drug therapy
for over two decades, new cases are being reported from
endemic regions in several countries without any reduction in
the annual new case detection rate.
India is a country in South Asia bounded by the Indian
Ocean on the south, the Arabian Sea on the south-west, and
the Bay of Bengal on the south-east. It is surrounded by
leprosy endemic countries such as Nepal, China, Bangladesh,
Sri Lanka and India’s Andaman and Nicobar Islands. In this
study, the samples were taken from different parts of India








FIG. 1. Distribution of single nucleotide polymorphism subtypes in Purulia district of West Bengal.
TABLE 3. Area-wise distribution of (a) subtype 2E in East
Delhi and (b) subtype 2G in Hoogly, West Bengal
Hospital name Area SNP type Subtype
(a)
TLM Shahdara Dilshad Garden Delhi 2 E
TLM Shahdara Tahirpur Delhi 2 E
TLM Shahdara Ghaziabad 2 E
TLM Shahdara Tahirpur Delhi 2 E
TLM Shahdara Sunder Nagari, Delhi 2 E
TLM Shahdara Seemapuri, Delhi 2 E
TLM Shahdara Johripur, Delhi 2 E
TLM Shahdara Raghuveernagar, Delhi 2 E
(b)
TLM Purulia Jhalda 2 G
TLM Purulia Hoogly 2 G
TLM Purulia Hoogly 2 G
TLM Purulia Hoogly 2 G
TLM Purulia Hoogly 2 G
TLM Shahdara At present living in Delhi
but essentially from Hoogly,
West Bengal
2 G
















FIG. 2. Distribution of single-nucleotide polymorphism subtypes in
Delhi, India.
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part of India. These M. leprae genotypes based on SNP
subtyping were from different geographical areas of India
that showed the presence of M. leprae with both type 1 and
type 2 SNPs. We found that most (92%) of the strains had
SNP type 1.
In some studies, it has been suggested that in endemic
countries >50% of patients with leprosy may have a history of
intimate contact with an infected person (often a household
member) [24]. Widespread exposure, as evidenced by nasal
presence of M. leprae in the endemic population [25], could
play an important role in maintaining endemicity of the disease
in certain areas. Transmission of leprosy can be by direct or
indirect means involving fomites but is thought to occur most
frequently through long-term direct contact with an infected
host [26]. The present study was therefore conducted to
understand the transmission and epidemiology of leprosy.
Several reports have published the usefulness of polymorphic
markers for M. leprae as an epidemiological tool in the
differentiation of strains of M. leprae [15,19,21, 23,27,28].
However, the polymorphism for each of these genomic
markers should be experimentally evaluated in the patient
populations of interest. The SNP types were examined based
on polymorphisms of nucleotides at positions 14676, 164275
and 2935685 of M. leprae genomic DNA. Four types of SNP—
type 1, CGA; type 2, CTA; type 3, CTC; and type 4, TTC—
were reported previously [18]. Our present study showed that
the M. leprae type belonged to SNP type 1 and 2 at a ratio of
92 : 8. This is in accordance with what has been reported by
previous studies in South Asia [19].
On further subtyping of these strains, we found the 1D
subtype to be predominant in our area (Table 2). Type 2G was
found only from strains from the coastal region of West
Bengal. Subtype 2G was also reported by Monot et al. [19]
from the population of Nepal and northern India. We analysed
subtype 2E from the samples of East Delhi where old leprosy
colonies were situated. Type 2E was also reported from
Malawi [19]. India was a home to the ancient Indus Valley
Civilization and a region of historic trade routes and vast
empires; the Indian subcontinent has been identiﬁed with
commercial and cultural wealth since ancient times. From the
Stone Age, people from different regions have migrated to
India and made it their home. Therefore, the population
comprises descendants of groups of people belonging to
almost all the ‘racial stocks’ of mankind and their admixtures,
who settled in India. A large slave trade took place in the 18th
and 19th centuries in Malawi, so at that time some M. leprae
ancestral lineages appear to have disseminated and become
established among the people of neighbouring and proximal
South-east Asian countries. Considering the above, the
ﬁndings of subtypes of M. leprae like that of Malawi were not
unusual. On the whole, our study showed a distribution of
M. leprae with the 1D SNP subtype being dominant, followed
by 1C, 1A and 2G from India, which is similar to that reported
from Nepal and Bangladesh [19]. One of the previous studies
from Western India in a rural and urban area near Mumbai
reported mainly subtype D, followed by B [29].
Data analysed from this study indicate that future epidemi-
ological studies involving SNP typing along with subtyping of
strains may give deeper insight into the distribution and
transmission patterns of M. leprae.
Acknowledgements
We wish to thank the Indian Council of Medical Research
(ICMR-Task Force Project No.5/8/3(12)/2009-ECD-I(A)) for
ﬁnancial support. We are also grateful to Mr Atul Roy for
assisting us in the sample collection. We thank the Superin-
tendent and staff of TLM, Shahdara, Purulia, Naini and Miraj for
their help and assistance during the ﬁeld work. We wish to
acknowledge the support of The Leprosy Mission, India to
carry out this work. We also acknowledge Dr Sunil Anand,
Director, TLM India, Dr PSS Sundar Rao, Dr Annamma John
Research Coordinator, TLM, India for their guidance and
encouragement.
Author Contribution
ML and RSJ conceived and designed the experiments. ML, RT
and MS performed the experiments; ML and SC analysed the
data; and ML, RSJ and US wrote the paper.
Transparency Declaration
All authors declare that there are no conﬂicts of interest.
Supporting Information
Additional Supporting Information may be found in the online
version of this article:
Figure S1. Sequence alignment for individual subtype.
References
1. World Health Organization (2011). Leprosy Update. Wkly Epidemiol
Rec 2011; 86: 389–400.
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases, CMI, 19, 1058–1062
CMI Lavania et al. SNP typing of Mycobacterium leprae 1061
2. Lavania M, Katoch K, Katoch VM et al. Detection of viable Mycobac-
terium leprae in soil samples: insights into possible sources of
transmission of leprosy. Infect Genet Evol 2008; 8: 627–631.
3. Turankar RP, Lavania M, Singh M, Siva Sai KS, Jadhav RS. Dynamics of
Mycobacterium leprae transmission in environmental context: decipher-
ing the role of environment as a potential reservoir. Infect Genet Evol
2012; 12: 121–126.
4. NLEP. Progress report as on 31 March 2012. 2012. Available at: http://
nlep.nic.in/data.html (last accessed 27 August 2012).
5. World Health Organization. Chemotherapy of leprosy for control
programmes. Report of a WHO Study Group. Geneva: World Health
Organization, 1982. TRS 675.
6. World Health Organization. Leprosy elimination campaigns: impact on
case detection. Wkly Epidemiol Rec 2003; 78: 9–16.
7. World Health Organization. Global leprosy situation, beginning of
2008. Wkly Epidemiol Rec 2008; 83: 293–300.
8. Blake LA, West BC, Lary CH, Todd JR 4th Environmental nonhuman
sources of leprosy. Rev Infect Dis 1987; 9: 562–577.
9. Izumi S . Subclinical infection by Mycobacterium leprae. Int J Lepr Other
Mycobact Dis 1999; 67: S67–S71.
10. Cole ST, Eiglmeier K, Parkhill J et al. Massive gene decay in the leprosy
bacillus. Nature 2001; 409: 1007–1011.
11. Matsuoka M, Maeda S, Kai M et al. Mycobacterium leprae typing by
genomic diversity and global distribution of genotypes. Int J Lepr Other
Mycobact Dis 2000; 68: 121–128.
12. Shin YC, Lee H, Lee H, Walsh GP, Kim JD, Cho SN. Variable numbers
of TTC repeats in Mycobacterium leprae DNA from leprosy patients
and use in strain differentiation. J Clin Microbiol 2000; 38: 4535–4538.
13. Fsihi H, Cole ST. The Mycobacterium leprae genome; systematic
sequence analysis identiﬁes key catabolic enzymes, ATP dependent
transport system and a novel pol(A) locus associated with genomic
variability. Mol Microbiol 1995; 16: 909–919.
14. Rastogi N, Goh KS, Berchel M. Species-speciﬁc identiﬁcation of
Mycobacterium leprae by PCR-restriction fragment length poly-
morphism analysis of the hsp65 gene. J Clin Microbiol 1999; 37: 2016–
2019.
15. Groathouse NA, Rivoire B, Kim H et al. Multiple polymorphic loci for
molecular typing of strains of Mycobacterium leprae. J Clin Microbiol
2004; 42: 1666–1672.
16. Truman R, Fontes AB, de Miranda AB, Suffys P, Gillis T. Genotypic
variation and stability of four variable-number tandem repeats and their
suitability for discriminating strains of Mycobacterium leprae. J Clin
Microbiol 2004; 42: 2558–2565.
17. Lavania M, Katoch K, Sharma R et al. Molecular typing ofMycobacterium
leprae strains from northern India using short tandem repeats. Indian
J Med Res 2011; 133: 618–626.
18. Monot M, Honore N, Garnier T et al. On the origin of leprosy. Science
2005; 308: 1040–1042.
19. Monot M, Honore N, Garnier T et al. Comparative genomic and
phylogeographic analysis of Mycobacterium leprae. Nat Genet 2009; 41:
1282–1289.
20. Matsuoka M, Roa RI, Budiawan T, Kyaw K, Chae GT. Genotypic
analysis of Mycobacterium leprae isolates from Japan and other Asian
countries reveals a global transmission pattern of leprosy. FEMS
Microbiol Lett 2006; 261: 150–154.
21. Truman RW, Singh P, Sharma R et al. Probable zoonotic leprosy in the
southern United States. N Engl J Med 2011; 364: 1626–1633.
22. Jadhav RS, Macdonald M, Bjune G, Oskam L MILEP2 Study Group.
Simpliﬁed PCR detection method for nasal Mycobacterium leprae. Int J
Lepr Other Mycobact Dis 2001; 69: 299–307.
23. Sakamuri RM, Miyako K, Li W et al. Population-based molecular
epidemiology of leprosy in Cebu, Philippines. J Clin Microbiol 2009; 47:
2844–2854.
24. Harrison’s Online. Chapter 166. Leprosy. The McGraw-Hill Compa-
nies. Available at: http://book.host.org/part%208.%20infectious%20dis-
eases/chapter%20166.%20leprosy.htm (last accessed 10 August 2012).
25. Smith WCS, Smith CM, Cree IA et al. An approach to understanding
the transmission of Mycobacterium leprae using molecular and immu-
nological methods: results from theMILEP2 Study. Int J Lepr Other
Mycobact Dis 2004; 72: 269–277.
26. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW,
Williams DL. The continuing challenges of leprosy. Clin Microbiol Rev
2006; 19: 338–381.
27. Zhang L, Budiawan T, Matsuoka M. Diversity of potential short tandem
repeats in Mycobacterium leprae and application for molecular typing.
J Clin Microbiol 2005; 43: 5221–5229.
28. Gillis T, Vissa V, Matsuoka M et al. Characterizations of short tandem
repeats for genotyping Mycobacterium leprae. Lepr Rev 2009; 80: 250–
260.
29. Kuruwa S, Vissa V, Mistry N. Distribution of Mycobacterium leprae
strains among cases in a rural and urban population of Maharashtra,
India. J Clin Microbiol 2012; 50: 1406–1411.
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases, CMI, 19, 1058–1062
1062 Clinical Microbiology and Infection, Volume 19 Number 11, November 2013 CMI
